204 related articles for article (PubMed ID: 2994936)
1. Technetium-99m glucoheptonate as a scanning agent in hepatocellular carcinoma.
Esser JD; Kew MC; Tobias M; Winterton R; Savitch I; Levin J
Clin Nucl Med; 1985 Aug; 10(8):586-8. PubMed ID: 2994936
[TBL] [Abstract][Full Text] [Related]
2. Uptake of Tc-99m di-isopropyliminodiacetic acid by hepatocellular carcinoma: concise communication.
Savitch I; Kew MC; Paterson A; Esser JD; Levin J
J Nucl Med; 1983 Dec; 24(12):1119-22. PubMed ID: 6315902
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HIDA hepatobiliary agent in the diagnosis of pulmonary metastasis from hepatocellular carcinoma.
Wang PW; Tai DI; Chen HY
Clin Nucl Med; 1991 Feb; 16(2):120-3. PubMed ID: 1848494
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m glucoheptonate in detection of lung tumors.
Vorne M; Sakki S; Järvi K; Vähätalo S
J Nucl Med; 1982 Mar; 23(3):250-4. PubMed ID: 6278110
[TBL] [Abstract][Full Text] [Related]
5. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
[TBL] [Abstract][Full Text] [Related]
6. Concentration and clearance of Tc-99m-pyridoxylidene isoleucine by a hepatoma.
Ueno K; Haseda Y
Clin Nucl Med; 1980 May; 5(5):196-9. PubMed ID: 6245828
[TBL] [Abstract][Full Text] [Related]
7. Uptake of Tc-99m-PIPIDA in pulmonary metastases from a hepatoma.
Cannon JR; Long RF; Berens SV; Caplan GE
Clin Nucl Med; 1980 Jan; 5(1):22-4. PubMed ID: 6243523
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of technetium-99m glucoheptonate and gallium-67 citrate thoracic imaging in detection of mediastinal and hilar involvement in primary lung cancer.
Taillefer R; Beauchamp G; Léveillé J
Clin Nucl Med; 1986 Jan; 11(1):15-9. PubMed ID: 3455906
[TBL] [Abstract][Full Text] [Related]
9. Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma.
Hasegawa Y; Nakano S; Hashizume T; Noguchi A; Ibuka K; Kasugai H; Kojima J; Ishigami S
Clin Nucl Med; 1989 Jul; 14(7):526-31. PubMed ID: 2548797
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-glucoheptonate lung imaging; has it a role in the diagnosis of bronchial carcinoma?
Langford JA; Miller RF; Pearson MC; Rudd RM
Nucl Med Commun; 1986 Dec; 7(12):907-14. PubMed ID: 3574793
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m glucoheptonate imaging in lung cancer and benign lung disease: concise communication.
Passamonte PM; Seger RM; Holmes RA; Hurst DJ
J Nucl Med; 1983 Nov; 24(11):997-1000. PubMed ID: 6313880
[TBL] [Abstract][Full Text] [Related]
12. [Study of space-occupying lesions in the liver using technetium-99m tin colloid and indium-113m chloride].
Nelson MJ; Klopper JF
S Afr Med J; 1985 Jan; 67(4):121-4. PubMed ID: 2982217
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gallium-67 citrate and technetium-99m glucoheptonate in the evaluation of pulmonary malignancies.
Vorne M; Alanko K; Järvi K; Lantto T; Mokka R; Sahlstöm K; Sakki S; Sallinen P; Vähätalo S
J Nucl Med; 1987 Apr; 28(4):442-6. PubMed ID: 3471889
[TBL] [Abstract][Full Text] [Related]
14. Cystic hypernephroma mimicking an hepatic mass.
Eybalin MC; Leblond R; Chartrand R; Carrier L; Picard D
Clin Nucl Med; 1984 Nov; 9(11):648-9. PubMed ID: 6509836
[TBL] [Abstract][Full Text] [Related]
15. Poor accumulation of technetium-99m glucoheptonate in sarcoidosis and other diffuse infiltrative lung diseases as compared with gallium-67 citrate.
Vorne M; Sahlström K; Alanko K
Clin Nucl Med; 1988 Feb; 13(2):107-9. PubMed ID: 3162408
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of the lung uptake in liver scanning using Tc-99m Sn colloid].
Shirato H; Itoh K; Saito C; Taneda M; Koshiba R; Furudate M; Irie G
Kaku Igaku; 1983 Jul; 20(6):823-9. PubMed ID: 6663897
[No Abstract] [Full Text] [Related]
17. Hepatoma visualization with Tc-99m pyridoxylidene glutamate.
Utz JA; Lull RJ; Anderson JH; Lambrecht RW; Brown JM; Henry W
J Nucl Med; 1980 Aug; 21(8):747-9. PubMed ID: 6249896
[TBL] [Abstract][Full Text] [Related]
18. Hepatoma: Tc-99m DISIDA uptake in primary and metastatic lesions.
Archibeque F; Williamson MR; Rosenberg R; Eisenberg B; Davis M
Clin Nucl Med; 1989 Sep; 14(9):706-7. PubMed ID: 2551557
[No Abstract] [Full Text] [Related]
19. Observations on the radionuclide assessment of peritoneovenous shunt patency.
Rosenthall L; Arzoumanian A; Hampson LG; Shennib H
Clin Nucl Med; 1984 Apr; 9(4):227-35. PubMed ID: 6233057
[No Abstract] [Full Text] [Related]
20. Radionuclide angiography and scintigraphy in hepatocellular carcinoma.
Friman L; Nilsson R; Udén R
Acta Radiol Diagn (Stockh); 1985; 26(5):577-80. PubMed ID: 3000140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
